株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

POC (ポイントオブケア) 診断の世界市場:業界の考察と将来予測

Point-of-Care Infectious Disease Diagnostics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

発行 Coherent Market Insights 商品コード 629681
出版日 ページ情報 英文 145 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.17円で換算しております。
Back to Top
POC (ポイントオブケア) 診断の世界市場:業界の考察と将来予測 Point-of-Care Infectious Disease Diagnostics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024
出版日: 2018年04月17日 ページ情報: 英文 145 Pages
概要

当レポートでは、世界のPOC (ポイントオブケア) 診断の市場について分析し、製品・技術の概要や、市場の基本構造および促進・抑制要因、全体的な市場規模の見通し、技術別・用途別・エンドユーザー別・地域別の詳細動向、主要企業のプロファイル、業界関係者が今後取り組むべき課題などを調査しております。

第1章 分析対象と前提条件

第2章 市場概略

  • 分析概要
  • エグゼクティブ・サマリー
  • COM (Coherent Opportunity Map:市場機会マップ)

第3章 市場のダイナミクス・規制・動向の分析

  • 市場のダイナミクス
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
  • 影響度の分析
  • PEST分析

第4章 世界のPOC (ポイントオブケア) 診断市場:技術別

  • イントロダクション
    • 市場シェア分析 (最新値・予測値)
    • 年間成長率 (今後9年間分)
    • 部門別の傾向
  • 側方流動
    • イントロダクション
    • 市場規模とその予測、年間成長率 (金額ベース、今後9年間分)
  • 凝集アッセイ
  • フロースルー
  • 固相アッセイ
  • バイオセンサー

第5章 世界のPOC診断市場:用途別

  • イントロダクション
  • 心血管代謝検査
  • 感染症検査
  • 腎臓検査
  • 薬物乱用 (DoA) 検査
  • 血糖検査
  • 妊娠検査
  • がんバイオマーカー検査
  • その他

第6章 世界のPOC診断市場:エンドユーザー別

  • イントロダクション
  • 病院
  • 在宅治療
  • 診断試験室
  • その他

第7章 世界のPOC診断市場:地域別

  • イントロダクション
  • 北米 (米国、カナダ)
    • 市場規模とその予測:技術別 (金額ベース、今後11年間分)
    • 市場規模とその予測:用途別 (金額ベース、今後11年間分)
    • 市場規模とその予測:エンドユーザー別 (金額ベース、今後9年間分)
    • 市場規模とその予測:国別 (金額ベース、今後9年間分)
  • 欧州 (英国、ドイツ、イタリア、フランス、スペイン、ロシアなど)
  • アジア太平洋地域 (中国、インド、日本、ASEAN諸国、オーストラリア、韓国など)
  • ラテンアメリカ (ブラジル、メキシコなど)
  • アフリカ (中部/南部/北部アフリカ諸国)
  • 中東 (湾岸協力会議 (GCC) 諸国、イスラエルなど)

第8章 競争環境

  • ヒートマップ分析
  • 企業プロファイル

第9章 付録

目次

Emerging economies such as Africa (West Africa), India, Brazil, and China have limited centralized laboratory facilities. In emerging economies point of care diagnostic is needed due to unavailability of labs, infrastructure, associated costs, and trained personnel. Most of the point-of-care diagnostic tests are comparatively easy to perform and can be performed with minimum amount of training. Infectious diseases such as HIV, Malaria, Tuberculosis, and others are highly prevalent in these emerging economies wherein point-of-care testing is a necessity. Furthermore, disease outbreaks are very frequent in these regions such as Yellow Fever disease outbreak in Nigeria and Brazil in December and November 2017, respectively and Acute Hepatitis E disease outbreak in Nigeria in July 2017, wherein point of care diagnostics could be helpful.

Market Dynamics

Technological advancements (innovative assays) to facilitate speedy diagnosis and extensive product portfolios of point of care infectious disease diagnostics offered by manufacturer's supports the growth of Point of Care Infectious Disease Diagnostics Market. Development of innovative point-of-care diagnostics for infectious diseases, wide applications in remote locations, constant disease outbreaks, and government funding for product development and research is expected to fuel growth of the market. The market is expected to gain significant growth, owing to increasing adoption of point-of-care diagnostics for infectious disease in remote locations, volume driven growth, and rising prevalence of infectious diseases such as HIV. Limited availability in emerging economies due to inventory issues and improper management, and result reliability issues are expected to hinder the market growth.

Key features of the study:

  • This report provides in-depth analysis of point of care infectious disease diagnostics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017-2025), considering 2016 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global point of care infectious disease diagnostics market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key companies covered as a part of this study include Danaher Corporation, Abbott Laboratories, Acon Laboratories, Inc., Hoffman-La Roche Ltd., Becton, Dickinson, and Company, Trinity Biotech Plc, AccuBioTech Co., Ltd. and Cardinal Health, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global point of care infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the point of care infectious disease diagnostics market

Detailed Segmentation:

  • Global Point of Care Infectious Disease Diagnostics Market, By Technology:
    • Lateral Flow
    • Agglutination Assays
    • Flow-Through
    • Solid Phase
  • Global Point of Care Infectious Disease Diagnostics Market, By Application:
    • HIV
    • Tropical Disease
    • Liver Disease
    • Inflammatory Disease
    • Respiratory Disease
    • Hospital Associated Infections (HAIs)
    • Sexual Health Disorders
    • Others
  • Global Point of Care Infectious Disease Diagnostics Market, By End User:
    • Hospitals
    • Diagnostic Laboratories
    • Home-Care Settings
    • Others
  • Global Point of Care Infectious Disease Diagnostics Market, By Geography:
    • North America
      • By Technology:
      • Lateral Flow
      • Agglutination Assays
      • Flow-Through
      • Solid Phase
      • By Application:
      • HIV
      • Tropical Disease
      • Liver Disease
      • Inflammatory Disease
      • Respiratory Disease
      • Hospital Associated Infections (HAIs)
      • Sexual Health Disorders
      • Others
      • By End User:
      • Hospitals
      • Diagnostic Laboratories
      • Home-Care Settings
      • Others
      • By Country:
      • U.S.
      • Canada
    • Europe
      • By Technology:
      • Lateral Flow
      • Agglutination Assays
      • Flow-Through
      • Solid Phase
      • By Application:
      • HIV
      • Tropical Disease
      • Liver Disease
      • Inflammatory Disease
      • Respiratory Disease
      • Hospital Associated Infections (HAIs)
      • Sexual Health Disorders
      • Others
      • By End User:
      • Hospitals
      • Diagnostic Laboratories
      • Home-Care Settings
      • Others
      • By Country:
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Technology:
      • Lateral Flow
      • Agglutination Assays
      • Flow-Through
      • Solid Phase
      • By Application:
      • HIV
      • Tropical Disease
      • Liver Disease
      • Inflammatory Disease
      • Respiratory Disease
      • Hospital Associated Infections (HAIs)
      • Sexual Health Disorders
      • Others
      • By End User:
      • Hospitals
      • Diagnostic Laboratories
      • Home-Care Settings
      • Others
      • By Country:
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
    • Latin America
      • By Technology:
      • Lateral Flow
      • Agglutination Assays
      • Flow-Through
      • Solid Phase
      • By Application:
      • HIV
      • Tropical Disease
      • Liver Disease
      • Inflammatory Disease
      • Respiratory Disease
      • Hospital Associated Infections (HAIs)
      • Sexual Health Disorders
      • Others
      • By End User:
      • Hospitals
      • Diagnostic Laboratories
      • Home-Care Settings
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East
      • By Technology:
      • Lateral Flow
      • Agglutination Assays
      • Flow-Through
      • Solid Phase
      • By Application:
      • HIV
      • Tropical Disease
      • Liver Disease
      • Inflammatory Disease
      • Respiratory Disease
      • Hospital Associated Infections (HAIs)
      • Sexual Health Disorders
      • Others
      • By End User:
      • Hospitals
      • Diagnostic Laboratories
      • Home-Care Settings
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Technology:
      • Lateral Flow
      • Agglutination Assays
      • Flow-Through
      • Solid Phase
      • By Application:
      • HIV
      • Tropical Disease
      • Liver Disease
      • Inflammatory Disease
      • Respiratory Disease
      • Hospital Associated Infections (HAIs)
      • Sexual Health Disorders
      • Others
      • By End User:
      • Hospitals
      • Diagnostic Laboratories
      • Home-Care Settings
      • Others
      • By Country:
      • Central Africa
      • South Africa
      • North Africa
  • Company Profiles
    • Danaher Corporation*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Abbott Laboratories
    • Acon Laboratories, Inc.
    • Hoffman-La Roche Ltd.
    • Becton, Dickinson, and Company
    • Trinity Biotech Plc
    • AccuBioTech Co., Ltd.
    • Cardinal Health, Inc.
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • PEST Analysis

4. Global Point of Care Infectious Disease Diagnostics Market, By Technology, 2015 - 2025 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2016 - 2025
    • Segment Trends
  • Lateral Flow
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Agglutination Assays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Flow-Through
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Solid Phase
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)

5. Global Point of Care Infectious Disease Diagnostics Market, By Application, 2015 - 2025 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2016 - 2025
    • Segment Trends
  • HIV
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Tropical Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Liver Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Inflammatory Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Respiratory Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Hospital Associated Infections (HAIs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Sexual Health Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)

6. Global Point of Care Infectious Disease Diagnostics Market, By End User, 2015 - 2025 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2016 - 2025
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Home-Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)

7. Global Point of Care Infectious Disease Diagnostics Market, By Regions, 2015 - 2025 (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, For Regions, 2016 - 2025
  • North America
    • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Application, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By End User, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Application, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By End User, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Application, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By End User, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Application, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By End User, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Application, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By End User, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
  • Middle East
    • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Application, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By End User, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Danaher Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Acon Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Hoffman-La Roche Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Becton, Dickinson, and Company
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Trinity Biotech Plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • AccuBioTech Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Cardinal Health, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top